Chronic Plaque Psoriasis
7 competing products in clinical development for Chronic Plaque Psoriasis.
Pipeline by Phase
Pre-clinical1
Phase 21
Phase 33
Approved2
All Products (7)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| alefacept + polyvalent pneumococcal vaccine | Astellas Pharma | Approved | Completed | 43 |
| alefacept | Astellas Pharma | Phase 3 | Completed | 40 |
| alefacept + placebo | Astellas Pharma | Phase 3 | Completed | 40 |
| Tildrakizumab + Placebo | Sun Pharmaceutical | Phase 3 | Completed | 40 |
| alefacept | Astellas Pharma | Approved | Terminated | 35 |
| E6201 0.005% + E6201 0.01% + E6201 0.03% + Placebo | Eisai | Phase 2 | Completed | 35 |
| Amevive exposure | Astellas Pharma | Pre-clinical | Terminated | 18 |